How do I calculate the effective serum osmolality to assess for hyperosmolar hyperglycemic state (HHS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Calculating Effective Serum Osmolality for HHS Assessment

To assess for hyperosmolar hyperglycemic state (HHS), calculate effective serum osmolality using the formula: 2 × [measured Na+ (mEq/L)] + glucose (mg/dL)/18. 1, 2, 3

The Formula and Its Application

The effective serum osmolality calculation is straightforward:

Effective Serum Osmolality = 2 × [measured Na+] + glucose/18

Where:

  • Sodium (Na+) is measured in mEq/L
  • Glucose is measured in mg/dL
  • The result is expressed in mOsm/kg

For HHS diagnosis, effective serum osmolality must be ≥320 mOsm/kg 1, 2, 3. However, recent evidence suggests that effective serum osmolality >300 mOsm/kg may be more sensitive for diagnosing HHS 4, 5.

Critical Distinction: Effective vs. Total Osmolality

The effective serum osmolality formula deliberately excludes urea (BUN) because urea freely crosses cell membranes and does not contribute to osmotic water shifts between compartments 1, 2, 3. This makes it the clinically relevant calculation for assessing hyperosmolar states.

In contrast, total serum osmolality includes urea:

  • Total osmolality = 2 × Na+ + glucose (mg/dL)/18 + BUN (mg/dL)/2.8 4
  • Total osmolality ≥320 mOsm/kg is the traditional HHS criterion 4

Use effective osmolality for clinical decision-making as it better reflects the true hyperosmolar burden driving water shifts and neurological complications 5.

Correcting Sodium for Hyperglycemia

A critical pitfall in HHS assessment is failing to recognize that measured sodium underestimates the true sodium concentration in the presence of severe hyperglycemia.

Corrected Na+ = measured Na+ + 0.024 × (glucose [mg/dL] - 100) 6

Or using the older correction factor: Corrected Na+ = measured Na+ + 1.6 × [(glucose - 100)/100] 1

Why This Matters

Recent evidence shows that 95.4% of HHS patients have hypernatremia when using corrected sodium, versus only 8% when using measured sodium 5. This means:

  • Measured sodium alone grossly underestimates the severity of hyperosmolarity
  • Corrected sodium better reflects true free water deficit
  • Management decisions should consider both measured AND corrected sodium values 5

Practical Clinical Algorithm

Step 1: Obtain measured sodium and glucose

  • Example: Na+ = 140 mEq/L, glucose = 900 mg/dL

Step 2: Calculate effective serum osmolality

  • 2 × 140 + 900/18 = 280 + 50 = 330 mOsm/kg

Step 3: Calculate corrected sodium

  • 140 + 0.024 × (900 - 100) = 140 + 19.2 = 159.2 mEq/L

Step 4: Interpret results

  • Effective osmolality 330 mOsm/kg (>320) = HHS criterion met
  • Corrected sodium 159.2 mEq/L (>145) = significant hypernatremia present
  • This patient has severe hyperosmolarity requiring aggressive fluid resuscitation

Additional Diagnostic Context

While calculating osmolality, remember that HHS diagnosis requires 2, 3:

  • Plasma glucose ≥600 mg/dL
  • Effective serum osmolality ≥320 mOsm/kg (or >300 mOsm/kg per newer criteria)
  • Arterial pH >7.30
  • Serum bicarbonate ≥15 mEq/L
  • Small or absent ketones

Important caveat: Recent data shows that 65.5% of HHS cases have concurrent DKA 5, so the traditional exclusion of significant ketonemia may need reconsideration in clinical practice. Don't dismiss HHS simply because ketones are present.

Monitoring During Treatment

During HHS management, recheck osmolality every 2-4 hours 1, 2. The goal is to decrease osmolality by 3-8 mOsm/kg/h 7, though some guidelines recommend <3 mOsm/kg/h 8. Faster correction risks osmotic demyelination syndrome and cerebral edema.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.